On 14 June 2023, the Senate referred an inquiry into Equitable access to diagnosis and treatment for individuals with rare and less common cancers, including neuroendocrine cancer to the Senate Community Affairs References Committee for inquiry and report by 21 March 2024. On 26 February 2024, the Senate granted an extension of time for reporting until 16 May 2024.
Further detail about the scope of the inquiry is provided in the terms of reference.
Submissions are sought by 31 August 2023.